Codiak BioSciences, Inc. (CDAK) Financial Statements (2024 and earlier)

Company Profile

Business Address 35 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:41,80056,50076,90098,600113,700130,300
Cash and cash equivalents41,78556,49476,93898,584113,681130,272
Other undisclosed cash, cash equivalents, and short-term investments156(38)161928
Prepaid expense   2,593   
Deferred costs   200   
Other undisclosed current assets14,20913,41310,4785,3135,6224,377
Total current assets:56,00969,91390,171103,913119,322134,677
Noncurrent Assets
Operating lease, right-of-use asset21,30421,63821,95721,25821,51921,767
Property, plant and equipment21,55722,45623,47929,38430,26330,885
Restricted cash and investments4,1704,1704,1704,1704,1704,170
Other undisclosed noncurrent assets29,67031,89331,893   
Total noncurrent assets:76,70180,15781,49954,81255,95256,822
TOTAL ASSETS:132,710150,070171,670158,725175,274191,499
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,8308,32411,54111,3139,4718,967
Employee-related liabilities    
Accounts payable1,1311,5161,8381,9981,7822,162
Accrued liabilities7,6996,8089,7039,3157,6896,805
Deferred revenue29244212,9639,3529,1174,345
Other undisclosed current liabilities2,8912,7752,6612,4382,3332,230
Total current liabilities:12,01311,54127,16523,10320,92115,542
Noncurrent Liabilities
Long-term debt and lease obligation58,95859,64760,31460,01660,53661,026
Long-term debt, excluding current maturities25,59625,51425,43025,35225,23025,095
Liabilities, other than long-term debt17,34130,50330,68641,39341,74646,008
Deferred revenue17,34130,50330,68641,39341,74646,008
Operating lease, liability33,36234,13334,88434,66435,30635,931
Derivative instruments and hedges, liabilities      
Other undisclosed noncurrent liabilities    207207207
Total noncurrent liabilities:76,29990,15091,000101,616102,489107,241
Total liabilities:88,312101,691118,165124,719123,410122,783
Equity
Equity, attributable to parent44,39848,37953,50534,00651,86468,716
Common stock222222
Additional paid in capital384,446381,652378,750375,913372,069367,112
Accumulated deficit(340,050)(333,275)(325,247)(341,909)(320,207)(298,398)
Total equity:44,39848,37953,50534,00651,86468,716
TOTAL LIABILITIES AND EQUITY:132,710150,070171,670158,725175,274191,499

Income Statement (P&L) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues13,14512,7047,6971,15789013,191
Sublease income850822662484348357
Gross profit:13,14512,7047,6971,15789013,191
Operating expenses(20,162)(20,955)(24,337)(22,653)(22,356)(23,138)
Operating loss:(7,017)(8,251)(16,640)(21,496)(21,466)(9,947)
Nonoperating income (expense)24222333,302(206)(343)(361)
Investment income, nonoperating34433,290495
Other nonoperating income848819617479352332
Interest and debt expense(649)(600)(605)(689)(704)(698)
Income (loss) from continuing operations:(7,424)(8,628)16,057(22,391)(22,513)(11,006)
Income (loss) before gain (loss) on sale of properties:(7,424)(8,628)16,057(22,391)(22,513)(11,006)
Other undisclosed net income  600605  698
Net income (loss):(7,424)(8,028)16,662(22,391)(22,513)(10,308)
Other undisclosed net income attributable to parent649  689704 
Net income (loss) available to common stockholders, diluted:(6,775)(8,028)16,662(21,702)(21,809)(10,308)

Comprehensive Income ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net income (loss):(7,424)(8,028)16,662(22,391)(22,513)(10,308)
Comprehensive income (loss):(7,424)(8,028)16,662(22,391)(22,513)(10,308)
Other undisclosed comprehensive income, net of tax, attributable to parent    689704 
Comprehensive income (loss), net of tax, attributable to parent:(7,424)(8,028)16,662(21,702)(21,809)(10,308)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: